Brain zaps

Brain zaps are brief, shock-like electrical sensations felt inside the skull, arising as a drug effect rather than a sign of neurological injury.

As a drug effect they are dose-proportional and characteristically appear as an aftereffect — during the comedown or in the days following use rather than at peak intoxication. They range from faint, barely-noticed pulses to jarring jolts that interrupt concentration or sleep, and are generally self-limiting.

Brain zaps are an uncommon but recognizable aftereffect, reported most often following stimulants such as MDMA, 6-APB, and 3,4-CTMP, and psychedelics such as psilocybin mushrooms, MDA, and 4-AcO-DMT. They also appear occasionally under cannabinoids such as THJ-018.

Brain zaps are felt as abrupt electrical jolts, each lasting a fraction of a second, centered in the head and sometimes radiating briefly down the neck.

They commonly arrive alongside a momentary sense of dizziness or disorientation, and may be accompanied by a faint ringing in the ears or a sense that the visual field has flickered. Attending to them — waiting for the next — tends to make them feel more frequent. At higher doses, particularly following serotonergic stimulants, they can cluster and become difficult to ignore.

Brain zaps arise through different pathways depending on the drug class:

• Stimulants — those with strong serotonin-releasing activity, such as MDMA and 6-APB, are most strongly associated; zaps emerge as acute serotonergic signaling drops off in the aftereffect phase.
• Psychedelics — serotonergic agents such as MDA and 4-AcO-DMT may provoke similar aftereffects through related disruption of serotonin transmission as the substance wears off.
• Cannabinoids — the mechanism is less established; how cannabinoid receptor modulation produces zap-like sensations is not well characterized.

How much each pathway contributes in a given case is not fully understood.

Who experiences brain zaps, and how strongly, varies widely. Higher doses and repeated or heavy use raise the likelihood, particularly under serotonergic stimulants. People with prior sensitivity to drug aftereffects or a history of frequent use are more likely to encounter them.

Expectation plays a role — those who know the effect and anticipate it on the comedown tend to report it more readily. Adequate rest and a light following day appear to reduce both frequency and intensity.